Skip to content

Drug interactions

Influenza virus vaccine quadrivalent recombinant + Temsirolimus

Severity: Minor

Influenza virus vaccine quadrivalent recombinant and Temsirolimus: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Temsirolimus is immunosuppressive and may blunt the antibody response to vaccination. The recombinant vaccine is non-live and safe to give, but protection may be lower than in immunocompetent patients.

What this interaction means in plain words

Influenza virus vaccine quadrivalent recombinant and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Moderate

Why it happens

mTOR inhibition suppresses lymphocyte proliferation and so reduces the immune response to vaccine antigens.

What to do

Vaccination is still recommended; ideally give it before starting temsirolimus or between cycles, and do not rely on it alone for protection.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Influenza virus vaccine quadrivalent recombinant and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Influenza virus vaccine quadrivalent recombinant with Temsirolimus?

MediHelp rates the interaction as minor. Influenza virus vaccine quadrivalent recombinant and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Temsirolimus is immunosuppressive and may blunt the antibody response to vaccination. The recombinant vaccine is non-live and safe to give, but protection may be lower than in immunocompetent patients.

How serious is the interaction between Influenza virus vaccine quadrivalent recombinant and Temsirolimus?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccination is still recommended; ideally give it before starting temsirolimus or between cycles, and do not rely on it alone for protection.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in